Sections of the site
Editor's Choice:
- Codes for GTA: San Andreas
- Prayer deceased brother from sister
- Why God allows suffering, illness and war and t
- Children's poem. Bookshelf - V. Vysotsky - Children's children's poems
- Why is it important to read the holy gospel and how to do it?
- Kazan Icon of the Mother of God
- Thank you very much for your attention
- Several interesting statements of the holy fathers about post
- Akathist Healer Great Panteleimonu on the health of sorrising
- Sunday, Sunday Day Orthodoxy Resurrection
Advertising
F Instructions for use. Gon-F lyophilisate: instructions for use. Impact on the ability to control vehicles and complex mechanisms |
The medicinal product of Italian origin with bizarre at first glance the name "Vessel Due F" is a natural substance obtained from the mucous membrane fine intestine Pig. This is a natural "mix" Mukopolisaccharides, 80% of which is the heparin-like fraction, and the remaining 20% \u200b\u200bdermatansulfate. pharmachologic effect This drug (and its international non-proprietary name sounds like Sulodexin), one way or another is associated with blood and vessels and is consistent with the summation of the finiginalitic (the ability to split fibrin, which is the basis of blood clots), antithrombotic (everything is clear), angioprotective (decrease in the permeability of vessel walls) and anticoagulant (prevent blood clotting) effects. The fast-flowing heparin-like fraction nourishes "related feelings" to antithrombin III, and dermatanova, in turn, has affinity for the Heparin II cofactor, which "disarms" the most important ingredient Blood coagulation systems - thrombin. Such, if described in a nutshell, the mechanism of anticoagulant action Vessel Due F. It develops due to the activation of the formation and release of prostacyclin (PGI2), a decrease in fibrinogen's blood concentration, inhibiting the activated X factor, etc. Determined by an increase in the blood content of plasminogen - the predecessor of the fabric activator of the plasmin, as well as the simultaneous decrease in the level of its inhibitor. An angioprotective effect of the drug is consisted of the regeneration of the morphological and functional integrity of endothelial vascular cells, normalizing the negative charges of pores of the basal vascular membranes. Additionally, the blood flow rate increases due to the reduction of triglyceride content (the drug activates the enzyme lipoproteinlipase, splitting triglycerides, which are included in the "bad" cholesterol). Thanks to its purely positive influence On the vascular channel, the drug finds use when various diseases Blood vessels of any localization, circulatory disorders, incl. caused by diabetes. Vessel Due F is produced in two dosage forms: Capsules and a solution for injecting administration. The solution is introduced both intramuscularly and intravenously (in the latter case, together with 150-200 ml of saline). At the beginning of the drug course for 15-20 days, 1 ampoule of the drug is used daily, then a transition to oral shape with a multiplication of reception 2 times a day is 1 capsule between the meals for 30-40 days. A full course of treatment must be repeated with periodicity at least 2 times a year. The attending physician may, at its discretion, change the dosing mode of the drug. PharmacologyAnticoagulant, heparinoid. It has antiagregative, antithrombotic, angioprotective, hypolypidemic and fibrinolytic effect. The active substance is an extract from the mucous membrane of the small intestine of animals, is a natural mixture of a fast-lived heparin-like fraction (80%) and dermatantium sulfate (20%). Suppresses the activated factor X, enhances the synthesis and secretion of prostacyclin (PGI2 prostaglandin), reduces the concentration of fibrinogen in the plasma. Increases the concentration of the activator of the tissue profibrinolysine (plasminogen) in the blood and reduces the concentration in the blood of its inhibitor. The mechanism of angioprotective action is associated with the restoration of the structural and functional integrity of the cells of the endothelium of the vessels, as well as the normal density of the negative electrical charge of the pores of the basal membrane of the vessels. Normalizes the rheological properties of blood by reducing TG and reduce blood viscosity. The effectiveness of the application is diabetic nephropathy Determined by a decrease in the thickness of the basal membrane and a decrease in the production of matrix by reducing the proliferation of Mesangium cells. When in / in the introduction in high doses, its anticoagulant action is manifested due to the inhibition of the HEPARIN COFACTOR II. Form releaseThe solution for V / B and V / M introduction of light yellow or yellow color, transparent. Auxiliary substances: sodium chloride, water d / and. 2 ml - dark glass ampoules with a volume of 2 ml (10) - packs cardboard. * - Lipoproteinlipasna unit. DosageIndividual, depending on the clinical situation. Side effectsFrom side digestive system: Nausea, vomiting, pain in the epigastric area. Others: skin rash; At the injection site - pain, burning, hematoma. IndicationsAngiopathy with increased risk of thrombosis (incl. After the myocardial infarction); Violation brain circulation (including an acute period of ischemic stroke and early recovery period); Discirculatory encephalopathy due to atherosclerosis, diabetes, arterial hypertension; vascular dementia; occlusal lesions of peripheral arteries (including atherosclerotic and diabetic genesis); phlebopathy, deep veins thrombosis; microangiopathy (nephropathy, retinopathy, neuropathy) and macroangiopathy sugar diabetes (diabetic foot syndrome, encephalopathy, cardiopathy); thrombotic states, antiphospholipid syndrome (as part of combined therapy with acetylsalicylic acid); To continue therapy with the development of heparinnidulated thrombotic thrombocytopenia. 1 capsule contains a mixture of ethyl esters of linoleic and linolenic acids 250 mg; Packaging 24 pcs. 1 g of ointment oily or bold - 20 mg; in tubes for 55 g pharmachologic effectpharmachologic effect - regenerating, antioxidant, normalizing lipid and carbohydrate exchange.Increases the formation of GHGs, normalizes the functions of the liver and the gastrointestinal tract, increases blood pressure, renal blood flow, prevents the excess deposition of cholesterol in tissues and slows down the sclerosis, promotes healing wounds and ulcers. Drug testimony Vitamin F99Capsules: Eczema (Seborin, Children's, Milk Strap), Liver Diseases, Digestion Disorders. Fat ointment: dry eczema, sensitive painful skin, skin cracks, ulceration, cuts, surface burns. Bold ointment: weakening eczema, milk paper, surface burns, cuts, varicose spikes, furunculosis. ContraindicationsHypersensitivity (including to individual components, the obturation of biliary tract and calculous cholecystitis (capsules). Side effectsNo detected. Method of application and doseInside, externally. Capsules (before meals, not chewing): Adults - in the middle daily dose of 3-6 caps. (no more than 8 caps.); Children, incl. Teenagers - 1-2 caps. (no more than 4 caps.). Ointment applies to a purified affected surface and the skin with a layer of 1-2 mm 2 times a day; If necessary, impose a bandage. PrecautionsIt is necessary to avoid falling ointment into the eyes and on the mucous membranes. Conditions for the storage of the drug Vitamin F99In a dry place, at room temperature.Keep out of the reach of children. The shelf life of Vitamin F995 years.Do not apply after the expiration date indicated on the package. Synonyms of nosological groups
URONORMIN-F: Instructions for use and reviews Uronicmine-F is an antibacterial drug used to treat infectious inflammatory diseases of the urinary tract. Release form and compositionDosage form - powder for the preparation of a solution for intake: granular, almost white or white, has a characteristic fruit smell (in a cardboard pack of 1-3 thermal packets from the Bufflen material containing 6 or 8 g of powder, and instructions for use of uronic F). In 1 packet of powder 2 or 3 g contained:
Pharmacological propertiesPharmacodynamicsThe composition of Uronormin-F includes phosphomycin [Mono (2-ammonium-2-hydroxymethyl-1,3-propandiol) (2r-cis) - (3-methoxiranyl) phosphonate], which is an anti-bacterial agent of a wide range of action, phosphonic acid derivative, intended for therapy of urinary tract infections. The mechanism of influence of the substance is based on the suppression of the first phase of the synthesis of the cell wall of the bacteria. Phosphomycin is a structural analogue of phosphoenolpyruvate and inhibits the EDF-N-acetylglucosamiennipurviferase enzyme irreversibly competitively. This enzyme catalyzes the reaction of the formation of UDF-N-acetyl-3-O- (1-carboxyvinyl) -d-glucosamine from UDF-N-acetyl-D-glucosamine and phosphoenolpiruvat. Also phosphomycin is able to reduce adhesion bacteria with mucous membranes bladderWhat can act as a predisposing factor for recurrent infections. Due to this mechanism, the cross-resistance of Uronic-F with other classes of antibiotics and mutual enhancement of action with combined use with other class antibiotics, for example, with β-lactam antibiotics are not developed. Phosphomycin shows activity in relation to wide spectrum Gram-negative and gram-positive microorganisms, which are usually allocated in urinary tract infections, including Escherichia Coli, Citrobacter SPP., Klebsiella SPP., Serratia SPP., Enterococcus Faecalis, Pseudomonas Aeruginosa, Proteus SPP. Resistance observed in laboratory conditions is associated with the mutation of UHP and GLPT genes, which monitor the transport of glucosophosphates and L-alpha-glycera phosphate, respectively. PharmacokineticsPhosphomycin after oral administration is absorbed from the intestines well, the substance reaches biological accessibility at about 50%. The maximum plasma concentration is 22-32 mg / l and is achieved in 2-2.5 hours. Plasma half-exploration period - 4 hours. When taking phosphomycin with food, suction slows down, but its concentration in the urine does not change. The substance is distributed in the walls of the bladder, kidneys, seed glands and a prostate. Its constant concentration in the urine, exceeding MBSC (minimum bacteriostatic concentration), is achieved 24-48 hours after oral administration. Phosphomycin with plasma proteins does not bind and overcomes the placental barrier. After one-time administration, the substance in small quantities is released into breast milk. Phosphomycin is removed mainly by the kidneys unchanged with glomerular filtration (40-50% dose is found in the urine), and the half-life period is approximately 4 hours, the substance is derived to a lesser extent (from 18 to 28% dose). URONORMIN-F, presumably, is subject to intestinal and hepatic recycling, because after 6 and 10 hours after the reception, the second peak serum concentration occurs. The pharmacokinetic properties of phosphomycin from age and pregnancy do not depend. In renal failure, the substance is cumulative; Between the speed of glomerular filtration and pharmacokinetic parameters of phosphomycin, a linear dependence is established. Indications for useUronicmine-F is prescribed for the treatment of infectious inflammatory diseases caused by sensitivity to the effects of phosphomycin by microorganisms:
When carrying out surgical interventions on urinary tracts and transurethral diagnostic studies Uronicmine-F is prescribed with a prophylactic goal. Contraindications
Pregnant Uronommin-F is appointed under medical control after assessing the ratio of expected benefits with a possible risk. Uronicmine-F, Application Instructions: Method and DosageUronicmine-f takes inside after emptying the bladder, an empty stomach (1 hour before or 2-3 hours after meals), preferably before bedtime. One-time dose should be divorced in 50-75 ml of water or a different drink, mix until complete dissolution, take immediately after the preparation of the solution. Multiplicity of reception - 1 time per day.
With the prophylactic goal of infection of urinary tract with transurethral diagnostic procedures and surgical intervention one-time dose Uronic-f is taken in 2 hours (children 5-12 years old) or 3 hours (children are 12-18 years old and adults) and 24 hours after intervention). In more severe cases (recurrent infections, elderly patients) after 24 hours additionally prescribed another one-time dose. Side effectsThe most common unwanted reactions to one-time reception of Uronormin-F include disorders from the digestion system, most often - diarrhea. These violations are passing and short-term. Information relating to phosphomycin overdose when oral administration are limited. Basic symptoms: hearing impairment, vestibular equipment functions, metal flavor In the mouth and the overall decrease in the perception of taste. Therapy: symptomatic and supporting. In order to increase the diuresis, a fluid intake is recommended inside. special instructionsIn the case of the development of hypersensitivity reactions, including anaphylactic shock Both anaphylaxis requires cancellation of Uronic-F and adequate treatment. During therapy, antibiotic-associated diarrhea is possible. Its severity can vary from a slight course to colitis, it is impossible to exclude the likelihood of death. Diarrhea, especially incessant, severe and / or with an admixture of blood, observed during the reception period or after the end of the phosphomycin treatment (including several weeks after treatment), may be a sign of a pseudommbranous colitis caused by Clostridium difficile. With an estimated / confirmed diagnosis, the therapy of the pseudo-membrane colitis is beginning immediately. In this clinical situation, the overwhelming intestinal peristalsis drugs are contraindicated. The concentration of phosphomycin in the urine in renal failure, if creatinine clearance is higher than 10 ml / min, after taking a conventional dose is stored for 48 hours. Passing hemodialysis Patients Uronormmin-F Powder is contraindicated. In diabetes, it is necessary to take into account that in 1 package with dosage 2 or 3 g contains 2.1 or 2.213 g of sucrose, respectively. Impact on the ability to control vehicles and complex mechanismsPatients when managing motor vehicles during therapy should take into account the likelihood of dizziness. Application during pregnancy and lactationDuring pregnancy, URONORMIN-F can only be applied in cases where the expected benefits above possible risk. When conducting limited studies, unwanted effects on pregnancy, the fruit or the health of the newborn were not identified. During the lactation, if necessary, the use of Uronic-F breast-feeding It should be interrupted. ChildcareThe use of URONORMIN-F powder is contraindicated in a dosage of 2 g children under 5 years of age; In the dosage of 3 g - children under 12 years old. With violations of the kidney functionURONORMIN-F Patients with clearance creatinine< 10 мл/мин (при тяжелой почечной недостаточности) не назначается. Medicinal interactionPossible interactions:
Against the background of antibiotic therapy, many cases of increased activity of anti-Vitamin K. antagonists have registered in patients with risk factors as inflammation, severe infection, poor general health or age, changing the IOM (international normalized relationship) may be due to infectious disease or evolve due to conducted Treatment. Such changes are presumably more characteristic of fluoroquinolones, macrolides, cyclines, co-trimoxazole and some cephalosporins. AnalogsThe analogues of Uronic-F are phosphorus Rompharm, eco-male, monural, oa, urophosfabol, phosmiscin, etc. Terms and conditions of storageStore at temperatures up to 25 ° C. Take care of children. Shelf life - 2 years. In ophthalmology, drugs are often used for local application. Eye drops can have a different appearance and purpose. So, drugs produce anti-inflammatory, vasoconstrictor, moisturizing or antimicrobial effect. Lower popularity have painkillers. One of these is the preparation "Diclo F" (Eye drops). Instructions for use of this fund will be described below. From the article you will also learn about the reviews that the medication has. general descriptionMedicine "Diclo F" - Eye drops. Instructions for use reports that they are intended for local use. The drug includes an active ingredient, its number of 1 millilitress of drugs is 0.1 milligrams. The preparation includes additional components: Dinatari Edetat, boric acid, Trometamine, castor oil and water for injection. Eye drops of "Diclo F 0.1%" in the amount of 5 milliliters are produced. The solution is placed in plastic packaging-dropper. Instructions for use are present in each pack. Store the tool is needed out of the reach of children. The ambient temperature should not exceed 30 degrees. At the same time, it is not at all be sure to place the medicine in the refrigerator. Use cold drops, according to patient reviews, not very nice. After the expiration date, the medicine is not allowed. How can I replace the medication?Does "Diclo F" (eye drops) analogues? Currently, such drugs with the same existing substance have a lot. Among them, they present drugs "Diklogen", "Voltaren OFTT", "Diklak", "Diclofenak" and so on. If we talk about the method of application, then among the analogs it is possible to allocate "Albucid", "visiting", "Tobradex", "dexamethasone" and so on. All of them can have other readings to use. That is why the analogue of one or another drug must be chosen along with a specialist. PurposeThe drug "Diclo F" (Eye Drops) Instructions for use advises to use only to appoint a doctor. It has the following testimony:
The drug "Diclo F" has a local anti-inflammatory, anesthetic and antipyretic effect. Information that needs to be taken into accountBefore using the diclo f (eye drops) medication, it is necessary to study contraindications. Even if the medication is assigned to an ophthalmologist, you need to read the instructions. If you have one or more contraindications, never apply the preparation described. Contact your doctor and tell about your situation. Medicine "Diclo F" is not assigned to increased sensitivity to diclofenac or any other component included in its composition. It is not used in some blood diseases. With extreme caution use medicine for the treatment of older people and patients with inflammatory diseases digestive tract. The medicine does not apply during the wearing contact lenses. The use of drops during pregnancy and breastfeeding is also prohibited. "Diclo F", Eye Drops: Instructions for useDepending on the testimony, the medication may have a different application scheme. So, to inhibit my hair and expanding the pupil, it is necessary to start using two hours before the operation. At the same time, four administrations of the medication in a conjunctival bag with an interval of about thirty minutes are made. If it is necessary to make prevention of cystic edema "Diclo F" (eye drops), instructions for use recommends to enter one drop to four times a day. The duration of application is determined by the doctor, depending on the outcome of the operation. If a specialist does not give individual appointments, then the drops are used for two weeks. As an anti-inflammatory or anesthetic drug, the drug is used for one or two weeks 2-4 times a day. Reactions to therapyAbout the preparation "Diclo F" (Eye Drops) Instructions for use informs that it has adverse reactions. Unwanted effects arise quite rarely with proper use. However, if you encountered them, you need to seek an ophthalmologist as soon as possible to correct therapy. Immediately after the instillation, the drug may cause burning, itching, clouding of the cornea and an ambiguity of view. Less often occur swelling and redness, urticaria. The medicine during improper use and use inside can cause nausea, diarrhea and abdominal pain. Treatment of adverse reactions is usually not required. They pass after the cancellation of the medication. Exceptions are only heavy allergic conditions. "Diclo F" (eye drops): reviewsMost patients who accounted for this drug remained satisfied with the result. In rare cases, adverse reactions were recorded and treatment was needed. Consumers report that immediately after installation can be easy sensations. The same arise when in the eye of ordinary water. However, after a few seconds, such symptoms pass. Some consumers mark chill or, on the contrary, warm in the area of \u200b\u200bthe eye after instillation. This situation is not a side effect and does not require discontinuation of therapy. When using the drug in prophylactic purposes, it shows positive results. Application Before the operation avoids the occurrence of a mine, which may affect the course of the procedure and aggravate the patient's condition. Consumers suggest that the Diclo F's medicine is inexpensive and affordable almost all of the segments of the population. At the same time, it shows good results of treatment and prevention and can be combined with many medicines. Therefore, it is often prescribed for the treatment of conjunctivitis as a symptomatic agent. Doctors remind that the break between the application of different medicines The area of \u200b\u200borgans should be at least half an hour. Otherwise, an unexpected reaction to mixing preparations may occur. Also, ophthalmologists advise on the time of therapy to stop wearing contact lenses. Some materials can deteriorate under the action of diclofenac. Give preference to ordinary points. Experts suggest that during the installation of the medication it is impossible to touch the pipette to the mucous membrane of the eye. It is recommended to store it after opening no more than one month. Let's summarize the articleYou learned about an anesthetic drug, which can also take inflammation. He has tradename "Diclo F". Eye dropsThe instruction to which you are presented to your attention can be purchased almost in any pharmacy. Some pharmacists require a recipe when selling. Therefore, it is necessary to take care of his receipt of the doctor in advance. The cost of the medication is available. You can buy one pack of drops about one hundred and fifty rubles. The price can slightly move in one direction or the other. Therefore, find out the details in a particular pharmacy. Much depends on the trading charge. Do not use the medication without appointing a doctor. Be sure to read the annotation, paying attention to the testimony and contraindications. Do not exceed the dose prescribed to you. With proper use of the drug, the positive effect is already noted immediately. All are good, do not get sick! This article allows you to familiarize yourself with the instructions for use. medicinal preparation Eskinor F.. Reviews of site visitors - consumers of this medicine, as well as the opinions of doctors of specialists in the use of Eskinor F in their practice. A big request to more actively add your reviews about the preparation: helped or did not help the medicine to get rid of the disease, which complications were observed and side effectsmay not be stated by the manufacturer in annotations. Analogs of Eskinur F in the presence of available structural analogues. The use of hormonal contraceptive for emergency postcoital contraception (after sexual intercourse) in women. The composition and side effects of the drug. Eskinor F. - This is a synthetic gestagen with contraceptive action, pronounced by gestagenic and anti-estrogenic properties. With the recommended dosing mode, the Levonorgestrel (the active substance of the drug Escynor f suppresses ovulation and fertilization, if the sexual contact occurred in the pre-deputy phase, when the possibility of fertilization is the largest. It may also cause changes in endometrials that prevent implantation. Increases the viscosity of the cervical mucus, which prevents the viscosity of the cervical mucus . The drug is not effective if implantation has already occurred. Reception of Eskinor F is recommended to start as soon as possible (but no later than 72 hours) after sexual intercourse, if no applied protective measures Contraception. The longer the time passed between the sexual act and the reception of the drug, the lower its efficiency (95% for the first 24 hours, 85% - from 24 to 48 hours, and 58% from 48 to 72 hours). Composition Levonorgestrel + excipients. Pharmacokinetics When orally admission, the levonorgestrel is quickly and almost completely absorbed. Absolute bioavailability is 100% of the adopted dose. After receiving 1 tablet, the Essinor F maximum concentration of the levonorestrel in serum is achieved after 1.6 hours. The levonorgestrel is associated with albumin serum and with globulin, binding sex hormones (GSPG). Only 1.5% of the entire dose is in free form, and 65% is connected with the GSPG. The drug penetrates breast milk. The levonorgestrel is hydroxylated in the liver, metabolites are derived in the form of conjugated glucuronides. Pharmacologically active metabolites of Levonorgestrel are unknown. The levonorgestrel is derived approximately equally to the kidneys and through the intestines exclusively in the form of metabolites. Indications
Forms of release Tablets 0.75 mg and 1.5 mg. Instructions for use and dosing mode The drug is accepted inside. Escynor F can be applied at any time. menstrual cycle. In the case of an irregular menstrual cycle, pregnancy must be preliminary. After receiving an emergency contraceptive to the onset of the next menstruation, local barrier contraceptives should be applied (for example, a condom, cervical cap). The use of the drug with a re-unprotected sexual intercourse during one menstrual cycle is not recommended due to an increase in the frequency of acyclic bleeding / bleeding. Tablets Escynor F 1,5 mg It is necessary to take 1 tablet as soon as possible, but no later than 72 hours, after unprotected intercourse. If within 3 hours after receiving the tablet, the Esquinor F 1,5 mg occurred, it should be taken another 1 tablet Escynor F 1,5 mg. Tablets Escynor F 0.75 mg It is necessary to take 2 tablets and no later than 72 hours after unprotected intercourse, while the second tablet should be taken after 12 hours (but not later than after 16 hours) after receiving the first tablet. To achieve a more reliable effect, both tablets should be taken as quickly after unprotected sexual intercourse (no later than 72 hours). If within 3 hours after the reception of the first or second tablet, the Escinkor F 0.75 mg occurred vomiting, then another 1 tablet Escynger f 0.75 mg should be taken. Pdurability
Contraindications
Application in pregnancy and breastfeeding Escyno F cannot be applied during pregnancy. If the pregnancy originated when applying an emergency method of contraception, then on the basis of the existing data of the adverse effect of the drug, the fruit is not expected. Levonorgestrel penetrates maternal milk. After taking the drug, breastfeeding should be stopped for 24 hours. Application in children Contraindicated B. childhood up to 16 years. In adolescents under 16, the use of the drug Eskinor F is only possible in exceptional cases (including with rape) and only after consulting the gynecologist. After emergency contraception, a re-consultation of the gynecologist is recommended. special instructions Escynor F should be used exclusively for emergency contraception. Repeated use of the drug Esquinor F for one menstrual cycle is not recommended. The medicine should be accepted as soon as possible, but no later than 72 hours, after unprotected intercourse. The effectiveness of emergency contraception during the delayed use of the drug is significantly reduced. The drug does not replace the use of permanent methods of contraception. In most cases, Escynor F does not affect the nature of the menstrual cycle. However, the appearance of acyclic bleeding and latency of menstruation for several days is possible. When menstruation delay is more than 5-7 days and change its character (scanty or abundant discharge) It is necessary to exclude pregnancy. The appearance of pain at thenime of the abdomen, fainting may indicate an ectopic (ectopic) pregnancy. Emergency contraception does not protect against sexually transmitted diseases. For diseases of the gastrointestinal tact (gastrointestinal tract), for example, with crown disease, the efficacy of the drug may decrease. Impact on the ability to driving vehicles and control mechanisms The effect of the drug ESKINOR F to control the car and other machines has not been investigated. In the event of dizziness development, you should refrain from driving vehicles and classes requiring increased concentration and speed of psychomotor reactions. Medicinal interaction With simultaneous reception of drugs of inductors of microsomal liver enzymes, the metabolism of the Levonorggestrel is accelerated. Reduce the effectiveness of Esquiner F can Amprenavir, Lansoprazole, Nevirapin, Okskarbazepine, Tharolimus, Topiramat, Trertinoin, Barbiturates (including Prison), Phenitoin and Carbamazepine, preparations containing John's jacket (Hypericum Perforatum), as well as rifampicin, rhythonavir, ampicillin, tetracycline, rifabutin , Griefullvin. ESKINOR F reduces the effectiveness of hypoglycemic and anticoagulant (derivatives of Kumarin, Phoenindion) medicines. Levonorgestrel increases plasma concentrations of glucocorticosteroids (GKS). Women taking these drugs should consult a doctor. Preparations containing levonorgestrel can increase the risk of cyclosporine toxicity, due to the suppression of its metabolism. Analogs of the drug Eskinor F Structural analogues for the acting substance:
Analogs of the drug therapeutic effect (contraceptive):
Review of the gynecologist's doctor In general, the drug Eskinor F is a good and effective contraceptive, but provided it is properly used. The adverse reactions to it are rarely developed, but again, subject to instructions for use. This rule, unfortunately, not always and not all women follow. Especially often young girls are addressed to me with complaints about bleeding or even bleeding from sex tract in the middle of the menstrual cycle. During the question, it turns out that the girls took the Eskinor-F tablets not one time per month. This was the cause of hormonal disorders. It is impossible to relate to the use of hormone contraceptives in no case, which I always warn my patients. In the absence of analogues of drugs on the active substance, you can follow the links below on the disease, which helps the appropriate drug, and see the analogues on therapeutic effects. |
Read: |
---|
Popular:
New
- Not lies, but alternative facts: Press Secretary Donald Trump quarreled with the press on the very first day of work in the White House
- Laura Ingrea is the future spokesman for Trump and her Russian children
- Alina Saprykin: "I want to liberate the territory first of all
- Victoria Beckham: the story of the transformation into "sullen non-versa" Victoria Beckham nose
- Marion Cotiyar Figure Parameters
- Horoscope Career for Lev for March
- Virgo - Astroprognosis for December
- Camping in Crimea Minich and Lassi
- Horoscope for June Taurus Horse
- Women Tiger Virgin Tiger Symbols and Talismans